Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis

Abstract

Background:

Infection with the Epstein-Barr virus (EBV) is associated with an increased risk of multiple sclerosis (MS).

Objective:

We sought genetic loci influencing EBV nuclear antigen-1 (EBNA-1) IgG titers and hypothesized that they may play a role in MS risk.

Methods:

We performed a genome-wide association study (GWAS) of anti-EBNA-1 IgG titers in 3599 individuals from an unselected twin family cohort, followed by a meta-analysis with data from an independent EBNA-1 GWAS. We then examined the shared polygenic risk between the EBNA-1 GWAS (effective sample size (N_eff) = 5555) and a large MS GWAS (N_eff = 15,231).

Results:

We identified one locus of strong association within the human leukocyte antigen (HLA) region, of which the most significantly associated genotyped single nucleotide polymorphism (SNP) was rs2516049 (p = 4.11 × 10⁻⁹). A meta-analysis including data from another EBNA-1 GWAS in a cohort of Mexican-American families confirmed that rs2516049 remained the most significantly associated SNP (p = 3.32 × 10⁻²⁰). By examining the shared polygenic risk, we show that the genetic risk for elevated anti-EBNA-1 titers is positively correlated with the development of MS, and that elevated EBNA-1 titers are not an epiphenomena secondary to MS. In the joint meta-analysis of EBNA-1 titers and MS, loci at 1p22.1, 3p24.1, 3q13.33, and 10p15.1 reached genome-wide significance (p < 5 × 10⁻⁸).

Conclusions:

Our results suggest that apart from the confirmed HLA region, the association of anti-EBNA-1 IgG titer with MS risk is also mediated through non-HLA genes, and that studies aimed at identifying genetic loci influencing EBNA immune response provides a novel opportunity to identify new and characterize existing genetic risk factors for MS.

Keywords

Epstein-Barr virus EBNA-1 multiple sclerosis GWAS polygenic risk non-HLA

Get full access to this article

View all access options for this article.

References

Lucas

Hughes

Lay

. Epstein-Barr virus and multiple sclerosis. J Neurol Neurosurg Psychiatry 2011; 82: 1142–1148.

Young

Rickinson

. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757–768.

Pender

. CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: A unifying hypothesis. Autoimmun Dis 2012; 2012: 189096.

Simpson

Jr Blizzard

Otahal

. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. J Neurol Neurosurg Psychiatry 2011; 82: 1132–1141.

Pakpoor

Disanto

Gerber

. The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: A meta-analysis. Mult Scler 2013; 19: 162–166.

Munger

Levin

O’Reilly

. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: A prospective study among United States military personnel. Mult Scler 2011; 17: 1185–1193.

Strautins

Tschochner

James

. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk. Mult Scler 2014; 20: 286–294.

Lunemann

Jelcic

Roberts

. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 2008; 205: 1763–1773.

Cepok

Zhou

Srivastava

. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005; 115: 1352–1360.

10.

Lunemann

Tintore

Messmer

. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol 2010; 67: 159–169.

11.

Farrell

Antony

Wall

. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 2009; 73: 32–38.

12.

Levin

Munger

Rubertone

. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293: 2496–2500.

13.

Lucas

Ponsonby

Dear

. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology 2011; 77: 371–379.

14.

Levin

Munger

O’Reilly

. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010; 67: 824–830.

15.

Ascherio

Munger

Lunemann

. The initiation and prevention of multiple sclerosis. Nat Rev Neurol 2012; 8: 602–612.

16.

Rubicz

Yolken

Drigalenko

. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). PLoS Genet 2013; 9: e1003147.

17.

Zhu

Montgomery

James

. A genome-wide scan for naevus count: Linkage to CDKN2A and to other chromosome regions. Eur J Hum Genet 2007; 15: 94–102.

18.

Wright

Martin

. Brisbane Adolescent Twin Study: Outline of study methods and research projects. Aust J Psychol 2004; 56: 65–78.

19.

Ferreira

Mangino

Brumme

. Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control. Am J Hum Genet 2010; 86: 88–92.

20.

Abecasis

Cherny

Cookson

. Merlin–rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30: 97–101.

21.

Almasy

Blangero

. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198–1211.

22.

Liu

Tozzi

Waterworth

. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 2010; 42: 436–440.

23.

International Multiple Sclerosis Genetics Consortium; Beecham

Patsopoulos

Xifara

. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353–1360.

24.

Lee

Bigdeli

Riley

. DIST: Direct imputation of summary statistics for unmeasured SNPs. Bioinformatics 2013; 29: 2925–2927.

25.

Patsopoulos

, Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011; 70: 897–912.

26.

Nyholt

. SECA: SNP effect concordance analysis using genome-wide association summary results. Bioinformatics 2014; 30: 2086–2088.

27.

International Schizophrenia Consortium; Purcell

Wray

Stone

. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748–752.

28.

Lin

Charlesworth

Stankovich

. Identity-by-descent mapping to detect rare variants conferring susceptibility to multiple sclerosis. PLoS ONE 2013; 8: e56379.

29.

Willer

Abecasis

. METAL: Fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010; 26: 2190–2191.

30.

Emily

Mailund

Hein

. Using biological networks to search for interacting loci in genome-wide association studies. Eur J Hum Genet 2009; 17: 1231–1240.

31.

Adzhubei

Schmidt

Peshkin

. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248–249.

32.

Kumar

Henikoff

. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009; 4: 1073–1081.

33.

Reva

Antipin

Sander

. Predicting the functional impact of protein mutations: Application to cancer genomics. Nucleic Acids Res 2011; 39: e118.

34.

Lim

Tang

. The Evi5 family in cellular physiology and pathology. FEBS Lett 2013; 587: 1703–1710.

35.

Hoppenbrouwers

Aulchenko

Ebers

. EVI5 is a risk gene for multiple sclerosis. Genes Immun 2008; 9: 334–337.

36.

Australia New Zealand Multiple Sclerosis Genetics Consortium. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41: 824–828.

37.

Mowry

Carey

Blasco

. Multiple sclerosis susceptibility genes: Associations with relapse severity and recovery. PLoS ONE 2013; 8: e75416.

38.

Van Aalderen

Remmerswaal

Verstegen

. Infection history determines the differentiation state of human CD8+ T cells. J Virol 2015; 89: 5110–5123.

39.

Parnell

Gatt

Krupa

. The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease. Clin Immunol 2014; 151: 16–24.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.55 MB